People who inject drugs (PWID) are at high risk of contracting and transmitting hepatitis C virus (HCV), with an estimated 20% of PWID in Australia having viraemic infection.
This bulletin examines the percentage of consumers reporting significant adverse effects following ‘ecstasy’ use in the preceding 12 months, and correlates of experiencing s
This bulletin uses the Perth Illicit Drug Reporting System (IDRS) data from 2013 to 2018 to explore evidence of impact of both peer-led naloxone programs since 2013, and the results of increased av
This bulletin examines trends in the national and jurisdictional use of capsules with unknown contents (e.g.
People who inject drugs are frequently affected by skin and soft tissue infections, which is associated with a number of health implications.
Use of methamphetamine has been of recent public health concern in Australia.
This bulletin examines trends in the Perth ecstasy market (e.g.
